Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31false2024-01-01falseNo description of principal activity12trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08399972 2024-01-01 2024-12-31 08399972 2024-12-31 08399972 2022-07-01 2023-12-31 08399972 2023-12-31 08399972 c:CompanySecretary1 2024-01-01 2024-12-31 08399972 c:Director1 2024-01-01 2024-12-31 08399972 c:RegisteredOffice 2024-01-01 2024-12-31 08399972 d:Buildings d:LongLeaseholdAssets 2024-01-01 2024-12-31 08399972 d:Buildings d:LongLeaseholdAssets 2024-12-31 08399972 d:Buildings d:LongLeaseholdAssets 2023-12-31 08399972 d:OfficeEquipment 2024-01-01 2024-12-31 08399972 d:OfficeEquipment 2024-12-31 08399972 d:OfficeEquipment 2023-12-31 08399972 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 08399972 d:ComputerEquipment 2024-01-01 2024-12-31 08399972 d:ComputerEquipment 2024-12-31 08399972 d:ComputerEquipment 2023-12-31 08399972 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 08399972 d:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 08399972 d:OtherPropertyPlantEquipment 2024-12-31 08399972 d:OtherPropertyPlantEquipment 2023-12-31 08399972 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 08399972 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 08399972 d:CurrentFinancialInstruments 2024-12-31 08399972 d:CurrentFinancialInstruments 2023-12-31 08399972 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 08399972 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 08399972 d:ShareCapital 2024-12-31 08399972 d:ShareCapital 2023-12-31 08399972 d:RetainedEarningsAccumulatedLosses 2024-12-31 08399972 d:RetainedEarningsAccumulatedLosses 2023-12-31 08399972 c:FRS102 2024-01-01 2024-12-31 08399972 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 08399972 c:FullAccounts 2024-01-01 2024-12-31 08399972 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08399972 6 2024-01-01 2024-12-31 08399972 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure
Company registration number: 08399972







UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2024


HCE MEDICAL GROUP LIMITED






































img365d.png                        

 


HCE MEDICAL GROUP LIMITED
 


 
COMPANY INFORMATION


Director
R S Singh 




Company secretary
M J Miles



Registered number
08399972



Registered office
Blays Cottage
Blays Lane

Englefield Green

Egham

Surrey

TW20 0PB




Accountants
Menzies LLP
Chartered Accountants

2nd Floor, Midas House

62 Goldsworth Road

Woking

Surrey

GU21 6LQ





 


HCE MEDICAL GROUP LIMITED
 



CONTENTS



Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 6


 


HCE MEDICAL GROUP LIMITED
REGISTERED NUMBER:08399972



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
12,327
18,530

Investments
 6 
2
2

  
12,329
18,532

Current assets
  

Debtors: amounts falling due within one year
 7 
1,576,535
1,041,593

Cash at bank and in hand
  
-
4,506

  
1,576,535
1,046,099

Creditors: amounts falling due within one year
 8 
(1,122,331)
(839,235)

Net current assets
  
 
 
454,204
 
 
206,864

Total assets less current liabilities
  
466,533
225,396

  

Net assets
  
466,533
225,396


Capital and reserves
  

Called up share capital 
  
2,300
2,300

Profit and loss account
  
464,233
223,096

  
466,533
225,396


Page 1

 


HCE MEDICAL GROUP LIMITED
REGISTERED NUMBER:08399972


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 June 2025.




................................................
R S Singh
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

HCE Medical Group Limited is a private company limited by shares incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of it's registered office is disclosed on the company information page. The group's principal place of business is the same as its registered office.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. 

 
2.3

Taxation

Tax is recognised in the Statement of income and retained earnings, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives as follows;

Depreciation is provided on the following basis:

Leasehold Improvements
-
over remaining length of lease
Office equipment
-
18% reducing balance
Computer equipment
-
18% reducing balance
Software costs
-
over 4 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 3

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 2).


4.


Exceptional items


The exceptional costs reflected in the year ended 30 June 2021 represents trade debtors that are considered irrecoverable.


5.


Tangible fixed assets





Leasehold Improvements
Office equipment
Computer equipment
Software
Total

£
£
£
£
£



Cost or valuation


At 1 January 2024
6,400
14,550
22,475
59,638
103,063



At 31 December 2024

6,400
14,550
22,475
59,638
103,063



Depreciation


At 1 January 2024
4,480
8,655
13,337
58,061
84,533


Charge for the year on owned assets
1,920
1,061
1,645
1,577
6,203



At 31 December 2024

6,400
9,716
14,982
59,638
90,736



Net book value



At 31 December 2024
-
4,834
7,493
-
12,327



At 31 December 2023
1,920
5,895
9,138
1,577
18,530

Page 4

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
2



At 31 December 2024
2





7.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
701,736
443,761

Other debtors
868,882
593,797

Prepayments and accrued income
5,917
4,035

1,576,535
1,041,593



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank overdrafts
3,729
-

Trade creditors
32,787
34,272

Amounts owed to group undertakings
6,637
-

Corporation tax
116,038
-

Other creditors
957,227
801,950

Accruals and deferred income
5,913
3,013

1,122,331
839,235



9.


Commitments under operating leases

At 31 December 2024 the Company had total future minimum lease payments due under non-cancellable operating leases of £9,875 (2023: £24,875).

Page 5

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Related party transactions


Brought forward 1.1.2024
Advances
Repaid
Carried forward 31.12.2024
£
£
£
£

Directors loan account
66,957
-
(71,957)
(5,000)
66,957
-
(71,957)
(5,000)

No interest was applied on this balance during the year.

Page 6